SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection
Clinical trial NCT03217617 · RECRUITING
Trial details
- NCT number
- NCT03217617
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-30
- Primary completion
- 2026-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.